Effect of endurance exercise training on the expression of GFAP, S100B, and NSE in the striatum of chronic/progressive mouse model of Parkinson's disease

NeuroRehabilitation

Volumn 28, Issue 4, 2011, Pages 359-363

  Al Jarrah, Muhammed D ^a   Jamous, Mohammed ^a  

^a JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

Author keywords

exercise; Parkinson's disease; striatum

Indexed keywords

1 METHYL 4-PHENYL 1,2,3,6 TETRAHYDROPYRIDINE; CALCIUM BINDING PROTEIN; GLIAL FIBRILLARY ACIDIC PROTEIN; NEURON SPECIFIC ENOLASE; PROBENECID; PYRIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN DAMAGE; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE COURSE; DOPAMINERGIC SYSTEM; ENDURANCE TRAINING; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PARKINSON DISEASE; PROTEIN EXPRESSION; TREADMILL;

ANALYSIS OF VARIANCE; ANIMALS; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; EXERCISE TEST; GENE EXPRESSION REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; MALE; MICE; MICE, INBRED C57BL; MPTP POISONING; NERVE GROWTH FACTORS; PHOSPHOPYRUVATE HYDRATASE; PHYSICAL ENDURANCE; S100 PROTEINS;

EID: 80051503943     PISSN: 10538135     EISSN: 18786448     Source Type: Journal    
DOI: 10.3233/NRE-2011-0664     Document Type: Article

References (22)

1. M. Al-Jarrah, M. Jamous, K. Al Zailaey and S. Bweir, Endurance exercise training promotes angiogenesis in the brain of chronic/progressive mouse model of Parkinson's Disease, Neurorehabilitation 26 (2010), 369-373.
2. M. Al-Jarrah M.-Pothakos, L. Pothakos K.- Novikova, I.V. Novikova L.-Smirnova, M.J. Smirnova Iv.- Kurz, L. Kurz Mj.- Stehno-Bittel, Y.S. Stehno-Bittel L.-Lau and Y.S. Lau, Endurance exercise promotes cardiorespiratory rehabilitation without neurorestoration in the chronic mouse model of parkinsonism with severe neurodegeneration, Neuroscience 149 (2007), 28-37. (Pubitemid 47488652)
3. C. Ammari M.-Gamez, A. Gamez C.-Lecomte, M. Lecomte A.-Sakly, H. Sakly M.- Abdelmelek, R. Abdelmelek H.-De Seze and R. De Seze, GFAP expression in the rat brain following sub-chronic exposure to a 900 MHz electromagnetic field signal, Int J Radiat Biol 86 (2010), 367-375.
4. R.B. Banati, S.E. Daniel and S.B. Blunt, Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease, Mov Disord 13 (1998), 221-227. (Pubitemid 28127795)
5. B.M. Bellander, I.H. Olafsson, P.H. Ghatan, H.P. Bro Skejo, L.O. Hansson, M. Wanecek and M.A. Svensson, Secondary insults following traumatic brain injury enhance complement activation in the human brain and release of the tissue damage marker S100B, Acta Neurochir (Wien), (2010).
6. C. Blesa J.- Juri et al., Progression of dopaminergic depletion in a model of MPTP-induced Parkinsonism in non-human primates. An (18)F-DOPA and (11)C-DTBZ PET study, Neurobiol Dis 38 (2010), 456-463.
7. P. Herrmann M.- Vos, M.T. Vos P.- Wunderlich, C.H. Wunderlich Mt.-de Bruijn, K.J. de Bruijn Ch.- Lamers and K.J. Lamers, Release of glial tissue-specific proteins after acute stroke: A comparative analysis of serum concentrations of protein S-100B and glial fibrillary acidic protein, Stroke 32 (2000), 2670-2677.
8. A. Higashino H.- Niwa, T. Niwa A.- Satou, Y. Satou T.-Ohta, S. Ohta Y.- Hashimoto,M. Hashimoto S.- Tabuchi, K. Tabuchi M.-Ooshima andK.Ooshima, Immunohistochemical analysis of brain lesions using S100B and glial fibrillary acidic protein antibodies in arundic acid- (ONO-2506) treated stroke-prone spontaneously hypertensive rats, J Neural Transm 116 (2009), 1209-1219.
9. S.J. Hornykiewicz O.-Kish and S.J. Kish, Biochemical pathophysiology of Parkinson's disease, Adv Neurol 45 (1987), 19-34.
10. B. Ingebrigtsen T.-Romner and B. Romner, Biochemical serummarkers for brain damage: A short review with emphasis on clinical utility in mild head injury, Restor Neurol Neurosci 21 (2002), 171-176. (Pubitemid 37330257)
11. C. L' Episcopo F.-Tirolo, N. Tirolo C.-Testa, S. Testa N.- Caniglia, M.C. Caniglia S.-Morale, B. Morale Mc.-Marchetti and B. Marchetti, Glia as a turning point in the therapeutic strategy of Parkinson's disease, CNS Neurol Disord Drug Targets 9 (2010), 349-372.
12. C. L' Episcopo F.-Tirolo, N. Tirolo C.-Testa, S. Testa N.- Caniglia, M.C. Caniglia S.-Morale, B. Morale Mc.-Marchetti and B. Marchetti, Glia as a turning point in the therapeutic strategy of Parkinson's disease, CNS Neurol Disord Drug Targets 9 (2010), 349-372.
13. P. Lamers Kj.-Vos, M.M. Vos P.-Verbeek, F. Verbeek Mm.- Rosmalen, W.J.A. Rosmalen F.-van Geel, B.G.M. van Geel Wj.-van Engelen and B.G. van Engelen, Protein S-100B, neuron-specific enolase (NSE), myelin basic protein (MBP) and glial fibrillary acidic protein (GFAP) in cerebrospinal fluid (CSF) and blood of neurological patients, Brain Res Bull 61 (2003), 261-264. (Pubitemid 36952472)
14. S. McGeer Pl.-Itagaki, B.E. Itagaki S.-Boyes, E.G. Boyes Be.-McGeer and E.G. McGeer, Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains, Neurology 38 (1988), 1285-1291.
15. H. Mirza B.-Hadberg, P. Hadberg H.-Thomsen, T. Thomsen P.-Moos and T. Moos, Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease, Mov Disord 13 (1998), 221-227.
16. H.G. Persson L.-Hardemark, J. Hardemark Hg.-Gustafsson, G. Gustafsson J.-Rundstrom, I. Rundstrom G.-Mendel- Hartvig, T. Mendel-Hartvig I.-Esscher, S. Esscher T.-Pahlman and S. Pahlman, S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: Markers of cell damage in human central nervous system, Stroke 18 (1987), 911-918.
17. M. Rothermundt M.- Peters, J.H.M. Peters M.-Prehn, V. Prehn Jh.-Arolt and V. Arolt, S100B in brain damage and neurodegeneration, Microsc Res Tech 60 (2003), 614-632.
18. D.V. Schaf, A.B. Tort, D. Fricke, P. Schestatsky, L.V. Portela and D.O. Souza, Rieder CR S100B and NSE serum levels in patients with Parkinson's disease, Parkinsonism Relat Disord 11 (2005), 39-43. (Pubitemid 40037596)
19. S. Schmidt, S100B: Pathogenetic and pathophysiologic significance in neurology, Nervenarzt 69 (1998), 639-646. (Pubitemid 28384770)
20. R.E. Sheng Jg.-Mrak, C.R. Mrak Re.-Rovnaghi, E. Rovnaghi Cr.-Kozlowska, L.J. Kozlowska E.-Van Eldik, W.S. Van Eldik Lj.-Griffin andW.S.Griffin, Human brain S100 beta and S100 beta mRNA expression increases with age: Pathogenic implications for Alzheimer's disease, Neurobiol Aging 17 (1996), 359-363. (Pubitemid 26200412)
21. J.B. Teismann P.-Schulz and J.B. Schulz, Cellular pathology of Parkinson's disease: Astrocytes, microglia and inflammation, Cell Tissue Res 318 (2004), 149-161. (Pubitemid 39362635)
22. V. Vila M.-Jackson-Lewis, C. Jackson-Lewis V.-Guegan, D.C. Guegan C.-Wu, P.Wu Dc.-Teismann, D.K. Teismann P.-Choi, K. Choi Dk.-Tieu, S. Tieu K.-Przedborski and S. Przedborski, The role of glial cells in Parkinson's disease, Curr Opin Neurol 14 (2001).